tiprankstipranks
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market
XTLB
XTL Biopharmaceuticals Sponsored ADR
RESEARCH TOOLSreports
Want to see XTLB full AI Analyst Report?

XTL Biopharmaceuticals Sponsored ADR (XTLB) Income Statement

141 Followers

XTL Biopharmaceuticals Sponsored ADR Income Statement

Last quarter (Q4 2024), XTL Biopharmaceuticals Sponsored ADR's total revenue was $289.00K, an increase of Infinity% from the same quarter last year. In Q4, XTL Biopharmaceuticals Sponsored ADR's net income was $-255.00K. See XTL Biopharmaceuticals Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 451.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.00K$ 0.00$ -1.00K$ -1.00K$ -1.00K
Operating Expenses
$ 2.17M$ 765.00K$ 880.00K$ 1.03M$ 948.00K
Depreciation and Amortization
$ 199.00K$ 1.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -930.00K$ -764.00K$ -879.00K$ -1.03M$ -947.00K
Operating Income
$ -2.17M$ -765.00K$ -880.00K$ -1.03M$ -948.00K
Other Income/Expenses
$ 1.01M$ -1.02M$ -468.00K$ 1.47M$ -2.01M
Pretax Income
$ -1.16M$ -1.78M$ -1.35M$ 435.00K$ -2.95M
Net Income
$ -1.03M$ -1.78K$ -1.35M$ 435.00K$ -782.00K
Per Share Metrics
Basic EPS
$ -9.60$ 0.00$ -16.00$ 5.12$ -36.48
Diluted EPS
$ -9.60$ 0.00$ -16.00$ 4.48$ -36.48
Weighted Average Shares Outstanding
 105.16K 85.15K 85.17K 83.12K 80.34K
Weighted Average Shares Outstanding (Diluted)
 110.03K 85.14K 85.14K 96.18K 80.34K
Currency in USD

XTL Biopharmaceuticals Sponsored ADR Earnings and Revenue History